August 27, 2015
Histogenics Corporation recently announced the appointment of Gloria Matthews, DVM, PhD, DAVCS, as chief medical officer.
Prior to joining the company, Matthews most recently served as senior director and global head of bone and joint research and development at Genzyme. Matthews will now oversee all clinical and medical affairs for Histogenics. According to a company release, she has over 20 years of global research, development and surgical experience in both orthopedics and cartilage repair.